Business Description
TheraCryf PLC
ISIN : GB00BSVYN304
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.96 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 9.1 | |||||
3-Year EPS without NRI Growth Rate | 10.6 | |||||
3-Year FCF Growth Rate | 9.1 | |||||
3-Year Book Growth Rate | -15.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.71 | |||||
9-Day RSI | 34.13 | |||||
14-Day RSI | 34.08 | |||||
6-1 Month Momentum % | -52.78 | |||||
12-1 Month Momentum % | -77.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.39 | |||||
Quick Ratio | 10.39 | |||||
Cash Ratio | 8.98 | |||||
Days Sales Outstanding | 166.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -513.96 | |||||
Net Margin % | -400.12 | |||||
FCF Margin % | -420.17 | |||||
ROE % | -61.29 | |||||
ROA % | -55.59 | |||||
ROIC % | -1025.04 | |||||
ROC (Joel Greenblatt) % | -2006.37 | |||||
ROCE % | -78.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.66 | |||||
PB Ratio | 0.57 | |||||
Price-to-Tangible-Book | 0.75 | |||||
EV-to-EBIT | 0.11 | |||||
EV-to-Forward-EBIT | -0.23 | |||||
EV-to-EBITDA | 0.11 | |||||
EV-to-Forward-EBITDA | -0.23 | |||||
EV-to-Revenue | -0.6 | |||||
EV-to-Forward-Revenue | 2.36 | |||||
EV-to-FCF | 0.09 | |||||
Price-to-Net-Current-Asset-Value | 0.75 | |||||
Price-to-Net-Cash | 0.75 | |||||
Earnings Yield (Greenblatt) % | 844.03 | |||||
FCF Yield % | -109.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TheraCryf PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 0.838 | ||
EPS (TTM) (£) | -0.012 | ||
Beta | 2.02 | ||
Volatility % | 44.3 | ||
14-Day RSI | 34.08 | ||
14-Day ATR (£) | 0.000659 | ||
20-Day SMA (£) | 0.007788 | ||
12-1 Month Momentum % | -77.63 | ||
52-Week Range (£) | 0.007 - 0.0405 | ||
Shares Outstanding (Mil) | 427.35 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TheraCryf PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TheraCryf PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
TheraCryf PLC Frequently Asked Questions
What is TheraCryf PLC(LSE:TCF)'s stock price today?
When is next earnings date of TheraCryf PLC(LSE:TCF)?
Does TheraCryf PLC(LSE:TCF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |